Corcept Therapeutics is scheduled to release its upcoming financial results and corporate update report for the quarter on November 3, 2026. Financial analysts and institutional investors closely monitor these scheduled quarterly earnings announcements for updated revenue guidance, prescription volume metrics, net income figures, and progress reports regarding ongoing clinical trials.